Development of an integrated microbiome-resistome surveillance framework for antimicrobial resistance and surgical site infection in veterinary orthopedic surgery

Active Cooperative Agreement Awarded

Award ID
U18FD008933
Recipient
Awarding agency
Obligated
$134,469

Award facts

Assistance listing
93.103 Food and Drug Administration Research
Completion date 8% complete
Funding agency
Food and Drug Administration Department of Health and Human Services
Place of performance
Manhattan, KS 66506, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services Food and Drug Administration awarded Kansas State University a cooperative agreement, U18FD008933, with $134,469 obligated on Sep 23, 2026, under the Food and Drug Administration Research program (CFDA 93.103). The award funds development of an integrated microbiome-resistome surveillance framework for antimicrobial resistance and surgical site infection (SSI) in veterinary orthopedic surgery.

The project pursues three aims. Aim 1 uses strain-level microbiome-genomic comparison to determine whether bacterial strains from clinical SSI cultures are present in the host's preoperative microbiome, supporting standardized antimicrobial resistance surveillance workflows. Aim 2 evaluates the association between the preoperative resistome and the development of prophylaxis-resistant infections, identifying specific resistance gene reservoirs. Aim 3 applies comparative genomic analysis to S. pseudintermedius strains from SSI wounds and apparently healthy surgical wounds, examining antimicrobial resistance genes, virulence factors, and SNPs/indels to distinguish pathogenic from commensal strains.

The source states the research aligns with the Center for Veterinary Medicine's goals to enhance monitoring of animal pathogens and promote antimicrobial stewardship. The place of performance is Manhattan, KS 66506, USA, and the ultimate completion date is Aug 31, 2028. The source does not identify sub-recipients for this award.

Description

Abstract
Rationale: surgical site infections (SSIS) and antimicrobial prophylaxis failure/resistance remain critical challenges in veterinary surgery, yet the origins of these pathogens are often unclear. This project investigates the hypothesis that preoperative microbial communities and resistome profiles serve as internal reservoirs for the pathogens and resistance determinants that cause postoperative SSIS and prophylaxis failure in animals. Aim 1: an integrated microbiome-genomic framework will be utilized to determine if bacterial strains identified in clinical SSI cultures are present in the host's preoperative microbiome. This strain-level comparison will enable the development of standardized antimicrobial resistance (AMR) surveillance workflows and prevention strategies to reduce the rate of SSIS. Aim 2: the project will evaluate the association between the preoperative resistome and the development of prophylaxis-resistant infections. By identifying specific resistance gene reservoirs, we can determine their direct relationship with prophylaxis failure, providing data crucial for antimicrobial stewardship. Aim 3: comparative genomic analysis will characterize S. Pseudintermedius strains isolated from SSI wounds versus apparently healthy surgical wounds. Specific focus will be on antimicrobial resistance genes, virulence factors, and genomic variations (SNPS/INDELS) to distinguish pathogenic from commensal strains, which will inform new preventive and treatment strategies. Significance: this research aligns with the center for veterinary medicine's (CVM) goal to enhance the monitoring of animal pathogens and promote antimicrobial stewardship. By shifting the focus toward the patient's own microbiome as a source of infection, this study provides a new framework for diagnostic laboratories to predict and prevent SSIS. Methodology: our approach leverages veterinary clinical surgery, bacteriological techniques, next generation sequencing (NGS) and advanced bioinformatics. Outcome: the expected results include a validated genomic workflow for strain tracking and actionable data for clinicians to refine antimicrobial prophylaxis. Ultimately, this will improve patient outcomes and reduce the use of antimicrobials in veterinary medicine.

Quick answers

Who received award U18FD008933?

U18FD008933 was awarded to Kansas State University by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 23, 2026.

How much is award U18FD008933 worth?

$134,469 has been obligated on U18FD008933.

Which agency awarded U18FD008933?

FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U18FD008933, with funding from Food and Drug Administration (Department of Health and Human Services).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award